Supply Chain

The EPCIS communications standard is “recommended,” and trading partners are identified

With a cost of approximately $514 million, expected completion is 2026

Logistics experts provide an outlook on what the industry must do to overcome potential bottlenecks

A conversation with ZS’s Maria Whitman and Anshul Agarwal

Marks the CDMO’s second plant in the country

Outlining ways visibility technology is solving pharma supply chain problems at a crucial time—and how digitization is the key

Containers to potentially be operational by next year, 2024 at the latest

Features an ATP solution to allow for efficiency

New Garner, NC location will be its first outside the Midwest

Will serve as a hub, as company aims for growth in the European region

A conversation with EY life sciences leaders Jim Welch and Jay Welsh

Proper control of type 1 and 2 diabetes can greatly reduce the personal impact and economic burden of this pervasive public health condition. To that end, stakeholders are exploring many parallel routes to help individuals and society maintain the upper hand, as the toll of diabetes continues to skyrocket

Pharma supply chain management will be one of the earliest beneficiaries of the Fourth Industrial Revolution, and the potential of ‘networks of networks’

Why ‘real-time-all-the-time’ supply chain operations are fundamental to biopharma success

The packaging and shipping of dangerous goods (DG) adds further challenges to the distribution pressures brought about by the pandemic

The clock is ticking on a massive effort to bring interoperable, electronic tracking of pharma shipments in the US

A recommended checklist for manufacturers as they enlist distributor and 3PL support—and the important questions they should be asking themselves

Pressure is mounting ahead of looming unit-level serialization required by the Drug Supply Chain Security Act—necessitating a wide scope of collaboration on compliance

Outlining the work of the Open Credentialing Initiative in establishing digital proof of identity, licensure status, and authorship using digital wallets and verifiable credentials

The crucial link of labeling and packaging in the pharma supply chain has its glory, but is not without its set of obstacles amid current market and global challenges

What makes a third-party logistics provider independent?

Drugmakers can turn to postponement, or late-stage customization, to help adapt approaches along the supply chain

Having recently led the launch of LogiCare3PL, Omar Agado of BioCare talks about what’s next for the growing third-party logistics space

Goal of ‘Closer to the Formulator’ is to offer a more efficient pharma production process

Deal establishes company’s presence in Mexico